中文产业新闻精选评分73Chinese source
默沙东Remigromig治疗DME的BRUNELLO试验一年数据达抗VEGF非劣效
默沙东发布首个在DME中与抗VEGF非劣效的3期数据，来自靶向Wnt通路的四价三特异性激动剂
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
默沙东发布首个在DME中与抗VEGF非劣效的3期数据，来自靶向Wnt通路的四价三特异性激动剂
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.